Related Experiment Video

Updated: Jul 17, 2026

Designing, Packaging, and Delivery of High Titer CRISPR Retro and Lentiviruses via Stereotaxic Injection
11:28

Designing, Packaging, and Delivery of High Titer CRISPR Retro and Lentiviruses via Stereotaxic Injection

Published on: May 23, 2016

Replication-competent vectors and empty virus-like particles: new retroviral vector designs for cancer gene therapy

Charlotte Dalba1, Bertrand Bellier, Noriyuki Kasahara

  • 1Biologie et Thérapeutique des Pathologies Immunitaires, CNRS, Université Pierre et Marie Curie-Paris, UMR 7087, Paris, France. charlotte.dalba@chups.jussieu.fr

Molecular Therapy : the Journal of the American Society of Gene Therapy
|January 25, 2007
PubMed

Insights

Retroviral vectors are crucial for gene therapy, with ongoing advancements addressing limitations like efficacy and safety. New designs enhance gene transfer for cancer therapy and antigen delivery.

Area of Science:

  • Molecular Biology
  • Gene Therapy
  • Virology

Background:

  • Murine oncoretroviral vectors pioneered gene therapy but faced challenges with in vivo efficacy and insertional mutagenesis.
  • These limitations spurred the development of novel retroviral vector designs.

Purpose of the Study:

  • To review the evolution and current status of retroviral vectors in gene therapy.
  • To highlight advancements in replication-competent and genome-free retroviral vectors.
  • To discuss future directions for improving retroviral vector technology.

Main Methods:

  • Review of existing literature on retroviral vector development and applications.
  • Analysis of different retroviral vector designs, including replication-defective, replication-competent, and genome-free vectors.
  • Discussion of strategies for enhancing vector safety and production.

Main Results:

  • Replication-competent vectors show improved in vivo cancer gene therapy efficacy.
  • Genome-free vectors are effective immunogens for antigen delivery.
  • Ongoing research focuses on improving safety and production efficiency for both vector types.

Conclusions:

  • Retroviral vectors, owing to their design versatility, remain vital tools in gene therapy.
  • Continuous innovation is addressing previous limitations, expanding their therapeutic potential.
  • Future developments promise safer and more efficient gene transfer applications.

More Related Videos

Production of Lentiviral Vectors for Transducing Cells from the Central Nervous System08:46

Production of Lentiviral Vectors for Transducing Cells from the Central Nervous System

Published on: May 24, 2012

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Retroviruses02:33

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...